1. Home
  2. VNCE vs CGTX Comparison

VNCE vs CGTX Comparison

Compare VNCE & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vince Holding Corp.

VNCE

Vince Holding Corp.

HOLD

Current Price

$6.28

Market Cap

101.1M

ML Signal

HOLD

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

HOLD

Current Price

$1.08

Market Cap

102.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VNCE
CGTX
Founded
2002
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.1M
102.9M
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
VNCE
CGTX
Price
$6.28
$1.08
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$5.17
$3.33
AVG Volume (30 Days)
358.7K
2.1M
Earning Date
04-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
132.45
62.79
EPS
N/A
N/A
Revenue
$300,007,000.00
N/A
Revenue This Year
$5.86
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.23
N/A
52 Week Low
$1.19
$0.52
52 Week High
$8.20
$3.83

Technical Indicators

Market Signals
Indicator
VNCE
CGTX
Relative Strength Index (RSI) 53.33 43.03
Support Level $2.41 $0.55
Resistance Level N/A $1.23
Average True Range (ATR) 0.95 0.18
MACD -0.08 -0.03
Stochastic Oscillator 44.38 16.87

Price Performance

Historical Comparison
VNCE
CGTX

About VNCE Vince Holding Corp.

Vince Holding Corp is a fashion brand that is engaged in wholesale and retail delivery of luxury essentials like women's and men's apparel, women's and men's footwear, and handbags. Its offers women's collections of luxurious cashmere sweaters and silk blouses, leather and suede leggings and jackets, dresses, denim, pants, tanks and t-shirts, and a growing assortment of outerwear. It focuses on developing an elevated collection of Vince apparel and accessories to serve the luxurious need of the customer. The company manages its business in three segments namely Vince Wholesale and Vince Direct-to-consumer. It operates its e-commerce business through its website. Maximum of its revenue generated from Vince Wholesale segment.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system (CNS) and retina. It aims to develop disease-modifying therapies for patients with these disorders. Its product candidate, zervimesine (CT1812), is an orally delivered small molecule designed to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, including beta-amyloid and alpha-synuclein. These protein oligomers have been linked to the progression of degenerative diseases such as Alzheimer's disease (AD) and dementia with Lewy bodies (DLB).

Share on Social Networks: